February 02, 2017
The temptation to use uncontrolled, early, small studies to support further development of products may prove problematic for emerging biopharma companies.
July 13, 2015
Synexus has announced plans to open three new research centers in Bulgaria, Poland and Romania.
May 29, 2015
Significant differences exist in the characteristics of the priority review drugs approved by the FDA and the European Medicines Agency.